SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Azerbaijan acquiring two reconnaissance satellites from Israel

Full list of Israeli high-tech funding rounds in 2023

Stampli raises $61 million led by Blackstone: “We will make Stampli one of the largest FinTech companies in the world”

PerfectScale raises $7.1 million for its Kubernetes optimization platform

Buzz

Most popular

Daily

Weekly

1

Advanced Israeli weaponry playing major role in Azerbaijan’s Nagorno-Karabakh offensive

2

Snyk losses surged to $267 million in 2022 despite 157% increase in revenue

3

Black Cube Moves into Larger, Fancier Headquarters

4

Stampli raises $61 million led by Blackstone: “We will make Stampli one of the largest FinTech companies in the world”

5

Is the iPhone 15 Pro worth the upgrade? In-depth review and analysis

Biotech

20 stories about Biotech

Scala Biodesign

Scala Biodesign exits stealth with $5.5 million in Seed to engineer future proteins

11.09.23|James Spiro

By fusing physics-based modeling, AI, and biological data analysis, Scala helps companies develop new medicines and foods faster and cheaper than before

IntraGel Founders

Intragel hopes to treat the 10% of inoperable cancer patients

The company has raised a total of $2 million for its first product, TumoCure, designed for solid tumors found in more than 17 million people.

מוסף שבועי 6.7.23 פרופ' צ'ארלס ברנר

"We won't get eternal life. Scientists who promise it are just selling BS"

16.07.23|Roni Dori

Forget about anti-aging treatments or drinking red wine. Prof. Charles Brenner bursts the balloon inflated by the booming longevity industry, and explains why there is no way to defeat death

Sharon Handelman-Gottlieb Adi eshel

From passion to innovation: Unleashing the power of FemTech in Israel's health landscape

13.06.23|Ariela Karmel

Sharon Handelman-Gotlib's journey to co-founding Shela and the promise of transformative women's health solutions

Environmental responsibility conference CTech Amir Oranim

“Bioplastics can replace any application of traditional fossil-based plastics”

01.05.23|Ariela Karmel

Amir Oranim, CEO and Co-Founder of TripleW, spoke to CTech at the Food Waste and Sustainability conference in Tel Aviv about why converting plastics is the best tool to address food waste

Maya Raya PoLoPo

“We can revolutionize the food industry by offering a sustainable and safer protein source”

PoLoPo has raised $1.75 million to develop the production of animal-based proteins in plants

ועידת לונדון 2023 פרופ יניב ארליך מנכ"ל Eleven Therapeutics

"We are revolutionizing the world of RNA"

Yaniv Erlich, CEO of Eleven Therapeutics, was speaking at the Mind the Tech conference in London

צוות Nectin Therapeutics

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

30.11.22|Meir Orbach

The Israeli company is aiming to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers

Bionaut Labs bags $43 million Series B for micro-robotic drug delivery

The biotech startup was co-founded by two Israeli robotics entrepreneurs, Michael Shpigelmacher and Aviad Maizels, who previously co-founded PrimeSense, sold to Apple in 2013 for approximately $400 million

מוח Brain Medtech

New treatment aiming to reduce suicidality in Bipolar Disorder

28.11.22|James Spiro

American-Israeli company NRx is currently undergoing a trial that combines two kinds of compounds hoping to reduce the negative side effects of current medicine

Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation

06.10.22|Golan Hazani

CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs

Sequentify raises $7 million to enable larger-scale DNA sequencing

The biotech startup will supply its next-gen sequencing libraries and software for cancer diagnostics, carrier screening, and Covid-19 monitoring

BioGenCell raises $16 million Seed round led by Marius Nacht for microvascular diseases treatment

09.05.22|Meir Orbach

The Israeli startup uses stem cells from the patient’s own blood to treat microvascular diseases and is aiming to develop products that may be usable to restore tissues damaged by diabetes, kidney failure, pulmonary hypertension, heart failure, stroke, blindness, and more

Marius Nacht: "I won’t have another success in high-tech like Check Point, but in biotech I will"

25.04.22|Meir Orbach and Diana Bahur Nir

Marius Nacht is one of the founding fathers of Israeli cybersecurity, but in recent years he has preferred to invest in biotech. In an exclusive interview with Calcalist, he tells how his interest in the life sciences arose, why it’s important to make long-term investments in Israeli companies, and why he left the digital bank and parted ways with the aMoon fund

Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro

The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level

Noam Solomon Immunai

When not knowing is a methodology

05.01.22|Noam Solomon

"When your culture celebrates that knowledge always starts from the lack thereof, people are rewarded for asking the right questions and not just for knowing the answers," writes Noam Solomon, CEO & Co-Founder of Immunai

צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22|Yafit Ovadia

Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions

ועידת היוניקורנס Noam Solomon

“What we are building is the Google Maps for the human immune system”

16.12.21|James Spiro

Speaking at the Unicorn Forum, Noam Solomon, CEO of Immunai, outlined an exciting prospect for the future of human health

מימין מריוס נכט וד"ר עידו בצ'לט

Mysterious Israeli biotech company raises $120 million Seed round five months after founding

08.12.21|Golan Hazani

The company named 1E Therapeutics was founded by Dr. Ido Bachelet and has received investments from the likes of Marius Nacht. It employs dozens of scientists working on an unspecified project related to drug development

מייסדי Immunai מימין לואיס וולוך ו נועם סולומון

Biotech startup Immunai earns unicorn status with $215 million Series B

27.10.21|Meir Orbach

The Israeli company has developed a technological platform that maps the entire immune system for better detection, diagnosis, and treatment of disease